KOLINPHARMA, 1H21 RICAVI A 5,1 mln Eu +110% vs 1H20, +65% VS 1H19. KPI PRESCRIZIONI 2Q21 A VOLUMI +88% VS 2Q20, +35% VS 2Q19.
vedi allegato
Leonardo_1H 2021 Results Presentation
Leonardo_1H 2021 Results Presentation
Leonardo: 1H 2021 key performance indicators
Leonardo: New Orders at € 6.7 bn (+9.5% YoY), Revenues at € 6.3 bn (+7.9% YoY), strong industrial performance (EBITA at € 400 mln, +37% YoY), and FOCF significantly improved (+26.9% YoY), these in summary are 1H 2021 key performance indicators. FY 2021 Guidance confirmed. Strong fundamentals supporting medium-long term growth.